Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor

@article{Howlett1990StereochemicalEO,
  title={Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor},
  author={A. Howlett and T. Champion and G. Wilken and R. Mechoulam},
  journal={Neuropharmacology},
  year={1990},
  volume={29},
  pages={161-165}
}
  • A. Howlett, T. Champion, +1 author R. Mechoulam
  • Published 1990
  • Biology, Medicine
  • Neuropharmacology
    • The recent preparation of the enantiomers of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl (THC-DMH), recrystallized to absolute enantiomeric purity, has made it possible to examine the requirement for stereospecificity for the interaction of this component with the cannabinoid receptor, defined by the binding of [3H]CP-55,940 and the adenylate cyclase enzyme. The enantiomer (-)11-OH-delta 8-THC-DMH exhibited a fully efficacious and potent (IC50 = 1.8 nM) inhibition of the accumulation of… CONTINUE READING
    View on Elsevier
    doi.org
    117 Citations
    Highly Influential Citations
    4
    Background Citations
    28
    Methods Citations
    5
    117 Citations
    Citation Type

    Citation Type

    The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-d-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain
    • 47
    One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
    • 11
    Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system.
    • 11
    Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.
    • 16
    Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.
    • 63
    Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens
    • 41
    Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models
    • 8
    • PDF
    The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940 (*)
    • 54
    • PDF
    Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
    • 760
    • PDF
    Derivatives of Dexanabinol. I. Water-Soluble Salts of Glycinate Esters
    • 4

    References

    SHOWING 1-10 OF 26 REFERENCES
    Stereochemical effects of 11-OH-Δ8-THC-dimethylheptyl in mice and dogs
    • 95
    Comparative Pharmacology of Δ9-Tetrahydrocannabinol and its Metabolite, 11-OH-Δ9-Tetrahydrocannabinol
    • 64
    • PDF
    Stereochemical requirements for cannabimimetic activity.
    • 30
    High-affinity cannabinoid binding sites in brain membranes labeled with [3H]-5'-trimethylammonium delta 8-tetrahydrocannabinol.
    • 46
    Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana
    • A. Howlett
    • Chemistry, Medicine
    • Neuropharmacology
    • 1987
    • 76
    Contribution of the metabolite 7-hydroxy-Δ1-tetrahydrocannabinol towards the pharmacological activity of Δ1tetrahydrocannabinol in mice
    • 43
    Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
    • J. Dill, A. Howlett
    • Chemistry, Medicine
    • The Journal of pharmacology and experimental therapeutics
    • 1988
    • 76
    Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
    • 238
    Determination and characterization of a cannabinoid receptor in rat brain.
    • 2,090
    • PDF
    Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
    • 340